There were 1,886 press releases posted in the last 24 hours and 439,457 in the last 365 days.

China Blood Testing (Typing, Immunoassay, NAT Testing) Market Report 2016 with Profiles of Abbott Laboratories, Bio-Rad Laboratories, DiaSorin & Grifols

Dublin, May 27, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Blood Testing Market in China (Typing, Immunoassay, NAT Testing)" report to their offering.

With a population of more than 1 billion, China is the world's largest country and therefore also its single largest potential market for goods and services. Blood Testing Market in China offers the most current look at the blood testing IVD market in China, including tests for blood typing, immunoassay-based tests and NAT Tests.

The report provides market analysis and data on the blood testing market environment in China, including:

  • Blood Center Stations in China by Type (Provincial, Regional, County, Cord, Plasma, Other)
  • China Blood Supply Statistics
  • Blood Supply Centers in Beijing
  • Blood Supply in China (tons)
  • Blood Supply in China (tons) by Type (Voluntary Unpaid Blood Donation/Paid Plasma Donation)
  • Blood Testing Market in China (Typing, Immunoassay, NAT), 2015 and 2020
  • Progress of Conversion (Provincial, Regional, County, Plasma Collection) Percentage Using NAT Testing

Blood Testing Market in China profiles companies in the market and speculates on the best opportunities for test makers. Companies profiled include:

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • DiaSorin
  • Grifols

Key Topics Covered:

CHAPTER ONE: EXECUTIVE SUMMARY
Overview
Chinese Healthcare and Blood Banking Environment
Scope and Methodology
Blood Testing Market in China
Major Findings of the Report

CHAPTER TWO: INTRODUCTION
Population Trends and Disease Demographics
Regulation and Policy Challenges for International Companies

CHAPTER THREE: BLOOD TESTING MARKET ENVIRONMENT IN CHINA
Tests Used in Blood Banking
Nucleic-Acid Testing (NAT)
Immunoassays
Typing
Blood Donation and Facilities Data for Specific Provinces

CHAPTER FOUR: MARKET ANALYSIS
Market Overview

CHAPTER FIVE: COMPANY PROFILES
Abbott Laboratories
Bio-Rad Laboratories, Inc.
DiaSorin
Grifols
Immucor
Ortho Clinical Diagnostics
PerkinElmer
Roche
China Health Labs & Diagnostics, Ltd.
Daan Gene Co., Ltd.

For more information visit http://www.researchandmarkets.com/research/l47993/blood_testing




CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716

         Sector: Healthcare and Medical Devices, In Vitro Diagnostics

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.